Raphael Wisniewski

Raphaël joined the Edmond de Rothschild Investment Partners’ Life Sciences team in 2001. Previously, he worked in Healthcare Corporate Finance at Goldman Sachs starting at Salomon Smith Barney. He worked also in the Finance Department of Health in London and in the finance department of General Healthcare in London, the private hospital group. Raphaël is a graduate of the Ecole des Hautes Etudes Commerciales and holds a postgraduate diploma in Economics and Finance from the Institut d’Etudes Politiques (IEP), Paris. Raphaël is a Director of Axonics, Cellnovo, Chase Pharmaceuticals, Genticel, Poxel, ReViral and MedDay.

< Back

Leave a Reply

Your email address will not be published. Required fields are marked *